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Condensation

Infants born to mothers with preeclampsia who had neutropenia and thrombocytopenia did not have an
increased occurrence of placental infarction or maternal vasculopathy but were more likely to be small for
gestational age (SGA) and of lower gestational age.

Abstract

Objective: To investigate the effect of placental pathology on neonatal white blood cells (wbc), platelets
(plt), hematocrit (hct) and nucleated red blood cells (nrbc) in very low birthweight (VLBW) infants born to
mothers with preeclampsia.
Study Design: Retrospective cohort study of infants with birthweight <1500g born to mothers with
preeclampsia from 7/2002-7/2006 at a single level 3 NICU. Placental pathology was reviewed for presence
placental infarction and vasculopathy. Hematologic parameters from day of life 0, 1, and 2 were obtained.
Statistical analysis included repeated measures ANOVA and multivariable analysis using logistic
regression.
Results: The study sample included 203 infants with EGA of 28 ± 3 weeks; 45% had placental infarctions
and 26% placental vasculopathy. Infants with neutropenia and thrombocytopenia did not have an increased
occurrence of placental infarction or maternal vasculopathy but were more likely to be SGA and of lower
gestational age compared to infants without neutropenia or thrombocytopenia. After multivariable analysis,

gestational age and SGA remained associated with both neutropenia and thrombocytopenia while placental
infarction and vasculopathy did not remain in the models.
Conclusions: In our population of VLBW infants born to mothers with preeclampsia, placental pathology
was common. There was no association of placental infarction or vasculopathy with neonatal neutropenia,
thrombocytopenia. The data suggest that neonatal hematologic effects of maternal preeclampsia, if related
to placental insufficiency, are associated with factors other than placental histology.
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Introduction
Preeclampsia is a common disorder of pregnancy affecting nearly 5-8% of pregnant women annually in the
United States. The NIH reported in the year 2000 that preeclampsia had risen by one-third over the
previous decade1. Preeclampsia is known to be a common cause of neonatal neutropenia and
thrombocytopenia. It has previously been postulated that both neonatal neutropenia and thrombocytopenia
result from decreased production of white blood cells and platelets from placental insufficiency 2-9.

Preeclampsia is also known to have associated placental pathology 10. Different placental histopathologies
are associated with specific clinical features of preterm preeclampsia. Severe maternal proteinuria is
related to placental chronic inflammation, while lower maternal antepartum platelet counts are related to
placental abruption and infarction. Lower birthweight percentiles and lighter placentas are directly
associated with uteroplacental vascular lesions 11.

To date, the link between different placental pathological conditions associated with preeclampsia and
neonatal neutropenia and thrombocytopenia have not been explored. In this study, we hypothesized that
there would be specific placental findings associated with neonatal hematologic abnormalities in infants
born to mothers with preeclampsia.

The purpose of this study was to investigate the association between placental pathology and neonatal
white blood cells (wbc), platelets (plt), hematocrit (hct) and nucleated red blood cells (nrbc) in VLBW
infants born to mothers with preeclampsia.

Methods
The study was a retrospective nested-cohort study of VLBW infants (<1500gm) born to mothers with
preeclampsia at Christiana Care Health System. Christiana Care Health System is the single level 3
regional NICU serving the state of Delaware. The study sample included inborn infants cared for between
July 2002 and July 2006. The study sample included only infants born to mothers with preeclampsia.

The diagnosis of preeclampsia was made by the attending obstetrician based on ACOG guidelines of
elevated blood pressure (>140 systolic or >90 diastolic) and proteinuria (>0.3gm of protein in a 24 hour
urine collection) after 20 weeks of gestation 12. For the purposes of this study, estimated gestational age
(EGA) was defined by best obstetric estimate. Small for gestational age (SGA) was defined as birth weight
<10%. Data on prenatal steroid administration was collected and mothers were classified as receiving
antenatal steroids if they received a minimum of 1 dose of betamethasone or dexamethasone prior to
delivery.

Clinical pathology reports were obtained on all infants. The decision to send the placenta for pathologic
evaluation was made by the attending obstetrician. The placentas were examined by one of nine attending
pathologists at Christiana Health Care System who were blinded to the clinical and hematologic outcomes
of the infants. The placentas were systematically reviewed according to the Placental Pathology Practice
Guideline Development Task Force 13. The reports were reviewed for placental abnormalities using
standard definitions for commonly described placental lesions 14. All the infants included in this study had
placental reports. Those born to mothers with preeclampsia who did not have a placental pathology report
were excluded from this study.

Infants in the study sample had complete blood counts (cbc) drawn as per NICU protocol. This included a
cbc on admission and the 1st two days of life. Cbc’s were obtained more frequently as clinically indicated.
Hematologic parameters investigated included total white blood cell count, platelet count, hematocrit, and
total nucleated red blood cells. All cbc’s were analyzed in standard fashion using a Coulter Counter
(Hialiah, FL). Total nucleated red blood cells were calculated by multiplying the total WBC count by the
number of NRBC counted per 100 WBC. .

Thrombocytopenia was defined as platelet count less than 100K/mm3 15. Neutropenia was defined by
Mouzhino criteria: absolute neutrophil count (ANC) less than 500 on day of life 0, ANC less than 2000 on
day of life 1, and ANC less than 1100 on day of life 2 16.

Statistics
Statistical analysis included both univariable and multivariable analysis. Univariable analysis included Chi
Square, Mann-Whitney U test, ANOVA, and repeated measures ANOVA as appropriate. Multivariable
analysis includes Logistic Regression. A p value <.05 was considered significant; all data are expressed as
mean ± SD.

Results
During the study period, 211inborn infants were born to mothers with preeclampsia. The final study
sample included 203 infants; 8 infants born to mother with preeclampsia were excluded as they did not
have placental pathology results. In the study sample, 30 infants were diagnosed with neutropenia and 48
infants with thrombocytopenia during the 1st 48 hours of life. The distribution of the placental pathologies
included: infarction (45%), maternal vasculopathy (26%), meconium staining (16%), histologic
chorioamnionitis (13%), calcification (9%) and funisitis (3%). Due to their prevalence, placental
infarction, maternal vasculopathy and placental calcifications were chosen to compare to the presence or
absence of neutropenia and thrombocytopenia, total nucleated red blood cells and hematocrit values.
Histologic chorioamnionitis was not considered in relationship to neonatal parameters as it was uncommon
and likely not related to maternal preeclampsia but rather other co-morbid factors.

Infants with neutropenia were of lower gestation, lower birth weight and more likely to be SGA compared
to the infants without neutropenia (Table 1). There were no differences in the occurrence of placental

infarction, placental vasculopathy or placental weight in the infants with neutropenia compared to those
without neutropenia. After multivariable analysis to control for potential confounding variables including:
gestational age, birthweight, race, SGA, multiple gestation, use of prenatal steroids, and placental
pathology, only gestational age (odds ratio of 1.3, 95% confidence 1.1-1.6) and SGA (odds ratio of 4.2 (CI
1.3-13.5) remained associated with neutropenia. Neither placental weight nor the presence of placental
infarction, calcification or vasculopathy was associated with neonatal neutropenia.

Similarly, infants with thrombocytopenia were also found to be of lower gestational age, birth weight and
more likely to be SGA. Again, there were no differences found in the occurrence of placental infarction,
placental vasculopathy, calcification, or placental weight when compared to the infants without
thrombocytopenia (Table 2). After multivariable analysis to control for potential confounding variables
including: gestational age, birthweight, SGA, multiple gestation, use of prenatal steroids and placental
pathology, only gestational age (OR 1.2 , 95% CI 1.0-1.4) and SGA (OR 4.2, CI 1.6-11) were associated
with an increased odds of thrombocytopenia. Neither placental weight nor the presence of placental
infarction, calcification, or vasculopathy was associated with neonatal neutropenia.

No association was found between the presence of placental infarction, placental calcification or placental
vasculopathies and hematocrit or nucleated red blood cells in the first 48 hours of life (data not shown).

Discussion
In our population of VLBW infants born to mothers with preeclampsia, placental pathology was common.
Despite the common occurrence of placental infarction and maternal vasculopathy, these findings were not
associated with neonatal neutropenia or thrombocytopenia. After controlling for potential confounding
variables lower birthweight, lower gestational age, and/or SGA remained associated with an increased odds
of neonatal thrombocytopenia and neutropenia.

Preeclampsia continues to be an increasing problem associated with preterm birth and is known to be a
common cause of neonatal neutropenia and thrombocytopenia 1. The incidence of neutropenia is reported
as high as 49% in pregnancy induced hypertension exposed infants 2. Consistent with our findings,
neutropenia severity has been correlated with the severity of growth restriction and prematurity 4. Kinetic
investigations have suggested that neutropenia in infants born to mothers with preeclampsia is secondary to
decreased production of white blood cells as evidenced by decreased circulating, marginated, storage,
progenitor and proliferative neutrophils 2. Our data suggest that the decreased production of white blood

cells is not associated with histologic changes in the placenta including placental infarction or
vasculopathy.

Early onset neonatal thrombocytopenia is most commonly observed secondary to placental insufficiency
with maternal hypertension being the biggest risk factor 17. Burrows and colleagues found that in
hypertensive mothers, preterm birth was the major risk factor for neonatal thrombocytopenia. Term infants
exposed to maternal hypertension had the same incidence of thrombocytopenia as the control population 5.
This finding suggests that hypertension effects may be of a different pathophysiologic pathway in term
versus preterm infants. This observation is consistent with our finding of thrombocytopenia associated with
lower gestational age in infants born to mothers with preeclampsia.

Preelcampsia is known to have associated placental pathology. Redline et al evaluated 609 placentas and
found most placental lesions prior to 37 weeks gestation, specifically maternal vasculopathy, villitis and
increased intervillous fibrin were increased in pregnancies complicated by hypertension 18. Soma et al
described that there are many microscopic findings common in the placentas of hypertensive patients.
These lesions included increased syncytial knots, villi hypovascularity, cytotrophoblastic proliferation, with
thickened basement membranes, atherosis of the spiral arteries and narrowed fetal capillaries 10. Different
placental histopathologies have been associated with specific clinical features of preterm preeclampsia.
Severe maternal proteinuria has been related to placental chronic inflammation, while lower maternal
antepartum platelet counts were related to placental abruption and infarction. In addition, lower birthweight
percentiles and lighter placentas were directly associated to uteroplacental vascular lesions 19. Ghidini’s
prospective study used a scoring system based on severity and extent of placental vascular and villous
lesions and found that the clinical diagnosis of preeclampsia increased with progressive uteroplacental
impairment 11. The lesions defined in Ghidini’s study were analyzed for more specific lesions than is
typically found in a standard placental pathology report and could not be applied to this study.

We were unable to show any association between placental pathology and neonatal hematologic
abnormalities. There are a number of potential explanations for this finding and our data should be

interpreted with caution. There may be no causal effect of placental pathology on neonatal neutropenia or
thrombocytopenia. Alternatively, placental pathology may still be associated with the hematologic effects
of maternal preeclampsia, however the placental pathologies leading to neutropenia or thrombocytopenia
may be different than those selected in this study. As our investigation was retrospective, we may have
missed some frequent subtle placental pathologies which may not have been routinely reported on clinical
pathology reports. Findings such as increased amounts of syncytial knots and necrosis, thickened
trophoblastic basement membranes, and narrowed fetal capillaries as previously discussed findings in
preeclamptic placentas tend to be subtle variations that are not typically commented upon in a routine
placental pathology analysis. In addition, some frequent findings in preeclampsia, such as meconium
staining may be too nonspecific to draw reliable conclusions from. It may be of benefit to form a
prospective study designed to have evaluations for specific placental lesions and then analyze if these
lesions have direct hematologic correlation.

It is plausible that the placental pathologies we investigated were not necessarily associated with
physiologic placental insufficiency. Perhaps other placental factors may be the causative agents of neonatal
hematologic aberrations. Histologic chorioamnionitis, common in preterm birth, has been associated with
increased levels of cord blood cytokines and increase intracranial hemorrhage in neonates 20-21.
Inflammation may have a contributing role and warrant further investigation in regards to preeclampsia and
neonatal neutropenia and thrombocytopenia. The number of infants born to mothers with histologic
chorioamnionitis in our study cohort was too small to make a meaningful association in our study.
Furthermore, histologic chorioamnionitis may have been associated with other co-morbidities such as
premature labor. Other limitations of our study may include the possibility of inter-observer variance and
lack of consensus on the diagnosis of placental lesions. However, adhering to methodical practice
guidelines at a single institution and standard definitions likely limited this variablity.

In conclusion, in our population of VLBW infants born to mothers with preeclampsia, placental pathology
was common. There was however no association of placental infarction or vasculopathy with neonatal

neutropenia, thrombocytopenia, or other hematologic parameters. Our data suggests that the neonatal
hematologic effects of maternal preeclampsia, if related to placental insufficiency, are associated with
factors other than placental histology.
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Table 1: Univariate Analysis of Neutropenia and Placental Pathologies, EGA, BW, Race, SGA, Multiple
Gestation, Prenatal Steroids
Neutropenia present, Neutropenia absent, p
n=30
n=173
EGA (weeks)

27.9 ± 2.1

29.3 ± 2.4

.02

BW (grams)

852 ± 283

1091 ±267

<.01

Placental Infarction

33%

46%

.20

Placental Calcification 10%

9%

.85

Maternal Vasculopathy 33%

25%

.41

Placental Weight
(grams)
Race
(Caucasian/African
American)
SGA

217 ± 37

245 ± 85

.17

31%/68%

50%/40%

.02

37%

15%

.01

Multiple Gestation

17%

16%

.93

Antenatal Steroids

83%

82%

.9

Table 2: Univariate Analysis of Thrombocytopenia and Placental Pathologies, EGA, BW, Race, SGA,
Multiple Gestation, Prenatal Steroids
Thrombocytopenia
Thrombocytopenia
p value
present, n=48
absent, n=155
EGA

28.3 ± 3

29.2 ± 2.3

.04

BW

882 ± 327

1073 ± 253

<.01

Placental Infarction

50%

44%

.47

Placental Calcification 10%

8%

.80

Maternal
Vasculopathy

25%

28%

.73

Placental Weight
(grams)
Race
(Caucasian/African
American)
SGA

231 ± 130

223 ± 70

.87

37%/50%

54%/41%

.06

43%

17%

<.01

Multiple Gestation

14%

18%

.53

Steroids

68%

69%

.84

